Today's blog features a Benefits Pro article that delves into the issue of patients paying out-of-pocket for brand name medicines on the full list price as well as cost sharing on nearly one out of five brand-name prescriptions. This is according to Amundsen Consulting, which went on to find in spite of “robust negotiations between biopharmaceutical
companies and payers,” health plans don’t pass along the savings
achieved via rebates and discounts on the price of medicines, but
instead still require patients with high deductibles or coinsurance to
pay up based on the medications’ full list price.
The article continues to tackle important issues in the healthcare industry including the role of PBMs and Medicare sufferers. Read more by clicking HERE for the full article.
HORIZON
Health Ventures is a healthcare cost management solutions company used
by insurance brokers, employee benefit consultants, third-party
administrators, insurance companies, and associations, to bring proven
thought leadership and strategy to the management of their clients
healthcare costs. To learn more about HHV and their services, please
visit http://horizonhealthventures.com/
No comments:
Post a Comment